entity

AD Pathology

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AD Pathology: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

20Connections
2Hypotheses
2Analyses
0Outgoing
20Incoming
0Experiments
3Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (20)

SourceRelationTypeStr
Aβ42:Aβ40 Ratiobiomarker_forbiomarker0.93
Amyloid Probability Score 2biomarker_forbiomarker0.93
MAPTassociated_withprotein0.92
GFAPindicatesprotein0.90
21098403suggestspaper0.90

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
APOE4 lipid dysregulation and synaptic phagocytosis as early 0.604 neurodegeneration AD Master Plan preregistration: APOE
Gut dysbiosis-driven monocyte reprogramming toward NETotic p 0.380 Alzheimer's disease Systemic immune profiling and peripheral

Mentioning Analyses (2)

Scientific analyses that reference this entity

Spatially Resolved Oligodendrocyte-Astrocyte Communication Networks Disrupted in

neurodegeneration | 2026-04-27 | 0 hypotheses

Proteomics Differential Expression in AD CSF and Brain Tissue

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.865

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

What spatially resolved cell-cell communication networks between oligodendrocyte

active · Rounds: 6 · Score: 0.83 · 2026-04-27

Which proteins are differentially expressed in AD CSF and brain tissue, and do t

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Is a 12-protein CSF panel superior to existing plasma p-tau217 for clinical AD p

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning AD Pathology in their description or question text

No additional research found